BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

XHSvsTMEDETF Comparison

ETF 1

XHS

State Street SPDR S&P Health Care Services ETF

This fund is part of

US Health Care

-2.15%

Full XHS fund page

VS

ETF 2

TMED

T. Rowe Price Health Care ETF

This fund is part of

US Health Care

-2.15%

Full TMED fund page

State Street SPDR S&P Health Care Services ETF (XHS) and T. Rowe Price Health Care ETF (TMED) belong to the same industry segment: US Health Care. XHS's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, TMED's top sector exposures are Healthcare, Consumer Non-Cyclicals and Non-Corporate. XHS is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.44% for TMED. XHS is up 26.65% year-to-date (YTD) with +$111M in YTD flows. TMED performs worse with 20.15% YTD performance, and +$13M in YTD flows. Run a side-by-side ETF comparison of XHS and TMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

XHS vs TMED performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 09/08/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	XHS TMED	-1.08%+2.00%	+16.30%+13.61%	+26.65%+20.15%	+35.80%+38.54%	+58.89%n/a	+23.34%n/a
Flows	XHS TMED	+$12M+$4M	+$99M+$10M	+$111M+$13M	+$112M+$15M	+$72M-	+$10M-

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	XHS TMED	+18.63%+17.62%	+17.60%+18.28%	+18.29%n/a	+21.34%n/a
Max drawdown	XHS TMED	-4.21%-4.40%	-11.97%-11.09%	-14.46%n/a	-29.93%n/a
Max drawdown duration	XHS TMED	65d31d	121d125d	250dn/a	1477dn/a

Trading data

Create an account to view trading data

Join for free

	XHS	TMED
Last sale 9/9/2026 at 3:10 PM	$134.82	$34.57
Previous close 09/08/2026	$135.28	$34.87
Consolidated volume 09/08/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of August 31, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

TMED

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	XHS	TMED
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 9/9/2026 at 3:10 PM

Live

Closed

	XHS	TMED
Last price	$134.82	$34.57
1D performance	-0.34%	-0.88%
AuM	$220.51 M	$33.88 M
E/R	0.35%	0.44%

Characteristics

	XHS	TMED
Management strategy	Passive	Active
Provider	State Street Investment Management	T. Rowe Price
Benchmark	S&P Health Care Services Select Industry Index	-
N° of holdings	60	97
Asset class	Equities	-
Trailing 12m distribution yield	Join	Join
Inception date	September 28, 2011	June 11, 2025
ESG	No	No

More XHS data on Trackinsight

More TMED data on Trackinsight

Exposure

Countries

XHS

USA

99.96%

Other

0.04%

TMED

USA

93.59%

Other

6.41%

Sectors

XHS

Healthcare

94.85%

Other

5.15%

TMED

Healthcare

98.58%

Other

1.42%

Diversification

XHS

Total weight of top 15 holdings out of 15

31.01%

TMED

Total weight of top 15 holdings out of 15

61.11%

Top 15 holdings

Data as of July 31, 2026

XHS

Tenet Healthcare Corp.

2.53%

NeoGenomics, Inc.

2.22%

PACS Group, Inc.

2.19%

Lifestance Health Group, Inc.

2.18%

U.S. Physical Therapy, Inc.

2.06%

Addus HomeCare Corp.

2.03%

Guardant Health, Inc.

2.03%

Acadia Healthcare Co., Inc.

2.03%

Chemed Corp.

2.00%

DaVita, Inc.

1.98%

Hinge Health, Inc.

1.97%

Progyny, Inc.

1.97%

GeneDx Holdings Corp.

1.96%

Concentra Group Holdings Parent, Inc.

1.95%

National HealthCare Corp.

1.93%

TMED

Eli Lilly & Co.

16.65%

UnitedHealth Group, Inc.

5.89%

Thermo Fisher Scientific, Inc.

4.44%

Alnylam Pharmaceuticals, Inc.

4.11%

Gilead Sciences, Inc.

3.76%

Danaher Corp.

3.58%

Cencora, Inc.

3.30%

Insulet Corp.

2.73%

Agilent Technologies, Inc.

2.69%

DexCom, Inc.

2.66%

Dyne Therapeutics, Inc.

2.60%

Stryker Corp.

2.49%

West Pharmaceutical Services, Inc.

2.29%

Waters Corp.

2.20%

McKesson Corp.

1.72%

Frequently asked questions about XHS and TMED

How have the XHS and TMED ETFs performed in 2026?

As of September 8, 2026, XHS is up 26.65% year-to-date (YTD), while TMED has returned 20.15%. That puts XHS better performer ahead so far this year.

Which ETF is attracting more investor money: XHS or TMED?

Year-to-date, the XHS ETF saw +$111M in flows, compared to +$13M for TMED.

Which ETF is more volatile: XHS or TMED?

Over the past year, XHS had a volatility of 17.6%, while TMED experienced 18.28%.

Which ETF is bigger: XHS or TMED?

As of September 8, 2026, XHS holds $220.51 M in assets under management (AUM), while TMED manages $33.88 M.

What sectors do the XHS and TMED ETFs invest in?

XHS leans toward sectors like Healthcare. Meanwhile, TMED focuses on Healthcare.

What are the top holdings of the XHS ETF and TMED ETF?

XHS top holdings include Tenet Healthcare Corp., NeoGenomics, Inc. and PACS Group, Inc.. TMED holds in its top three: Eli Lilly & Co., UnitedHealth Group, Inc. and Thermo Fisher Scientific, Inc..

XHSvsTMEDETF Comparison

State Street SPDR S&P Health Care Services ETF

T. Rowe Price Health Care ETF

XHS vs TMED performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the XHS and TMED ETFs performed in 2026?

As of September 8, 2026, XHS is up 26.65% year-to-date (YTD), while TMED has returned 20.15%. That puts XHS better performer ahead so far this year.

Which ETF is attracting more investor money: XHS or TMED?

Year-to-date, the XHS ETF saw +$111M in flows, compared to +$13M for TMED.

Which ETF is more volatile: XHS or TMED?

Over the past year, XHS had a volatility of 17.6%, while TMED experienced 18.28%.

Which ETF is bigger: XHS or TMED?

As of September 8, 2026, XHS holds $220.51 M in assets under management (AUM), while TMED manages $33.88 M.

What sectors do the XHS and TMED ETFs invest in?

XHS leans toward sectors like Healthcare. Meanwhile, TMED focuses on Healthcare.

What are the top holdings of the XHS ETF and TMED ETF?

XHS top holdings include Tenet Healthcare Corp., NeoGenomics, Inc. and PACS Group, Inc.. TMED holds in its top three: Eli Lilly & Co., UnitedHealth Group, Inc. and Thermo Fisher Scientific, Inc..

Which ETF is more diversified: XHS or TMED?

XHS holds 60 securities with 31.01% of its assets in the top 15. TMED has 97 securities and a top 15 weight of 61.11%.

Have you tried our ETF Compare tool?